Stocks and Investing Stocks and Investing
Fri, November 19, 2021

Jailendra Singh Maintained (TDOC) at Buy with Decreased Target to $207 on, Nov 19th, 2021


Published on 2024-10-27 18:43:48 - WOPRAI, Jailendra Singh
  Print publication without navigation


Jailendra Singh of Credit Suisse, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $208 to $207 on, Nov 19th, 2021.

Jailendra has made no other calls on TDOC in the last 4 months.



There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 3 agree with Jailendra's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $150 on, Thursday, October 28th, 2021
  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, August 2nd, 2021
  • George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $153 on, Wednesday, July 28th, 2021


These are the ratings of the 5 analyists that currently disagree with Jailendra


  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $215 on, Monday, November 15th, 2021
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $165 on, Friday, October 29th, 2021
  • Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $170 on, Thursday, October 28th, 2021
  • Charles Ryhee of "Cowen & Co." Maintained at Buy with Decreased Target to $188 on, Monday, August 9th, 2021
  • Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $180 on, Wednesday, July 28th, 2021
Contributing Sources